Sustained-release levodopa in Parkinsonism.
作者信息
Curzon G, Friedel J, Grier L, Marsden C D, Parkes J D, Shipley M, Zilkha K J
出版信息
Lancet. 1973 Apr 7;1(7806):781. doi: 10.1016/s0140-6736(73)92182-x.
PMID:4120768
Abstract
摘要
相似文献
1
Sustained-release levodopa in Parkinsonism.帕金森病中的缓释左旋多巴
Lancet. 1973 Apr 7;1(7806):781. doi: 10.1016/s0140-6736(73)92182-x.
2
Sustained-release levodopa.缓释左旋多巴
Lancet. 1973 Jun 16;1(7816):1391. doi: 10.1016/s0140-6736(73)91718-2.
3
Slowly absorbed L-dopa preparation in the treatment of parkinsonism.缓释左旋多巴制剂治疗帕金森病
Acta Neurol Scand. 1973;49(3):331-8. doi: 10.1111/j.1600-0404.1973.tb01306.x.
4
Sustained-release levodopa in parkinsonism.帕金森病中的缓释左旋多巴
Lancet. 1973 Feb 24;1(7800):431-2. doi: 10.1016/s0140-6736(73)90295-x.
5
Levodopa and orphenadrine hydrochloride in Parkinsonism.
Eur J Clin Pharmacol. 1971 Dec;4(1):18-21. doi: 10.1007/BF00568893.
6
MK 486 and levodopa in treatment of Parkinsonism.
Dis Nerv Syst. 1973 Apr-May;34(4):167-71.
7
Levodopa in parkinsonism.帕金森病中的左旋多巴。
Practitioner. 1972 May;208(247):695-9.
8
Levodopa therapy effects on natural history of Parkinsonism.
Arch Neurol. 1972 Dec;27(6):481-5. doi: 10.1001/archneur.1972.00490180017005.
9
Injected apomorphine and orally administered levodopa in Parkinsonism.帕金森病中注射用阿扑吗啡与口服左旋多巴
Arch Neurol. 1972 Dec;27(6):474-80. doi: 10.1001/archneur.1972.00490180010004.
10
Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Neurology. 1974 May;24(5):482-6. doi: 10.1212/wnl.24.5.482.
引用本文的文献
1
Anti-parkinsonian drugs today.当今的抗帕金森病药物。
Drugs. 1984 Sep;28(3):236-62. doi: 10.2165/00003495-198428030-00002.
2
Clinical pharmacokinetics of anti-parkinsonian drugs.抗帕金森病药物的临床药代动力学
Clin Pharmacokinet. 1987 Sep;13(3):141-78. doi: 10.2165/00003088-198713030-00002.
3
Controlled-release levodopa/benserazide (Madopar HBS): clinical observations and levodopa and dopamine plasma concentrations in fluctuating parkinsonian patients.控释左旋多巴/苄丝肼（美多芭HBS）：波动性帕金森病患者的临床观察及左旋多巴和多巴胺血浆浓度
J Neurol. 1990 Feb;237(1):24-8. doi: 10.1007/BF00319663.
Zotero 插件